Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract
Differentiated thyroid carcinomas usually show good uptake and response to I-131 ablative treatment. In this study, 90 patients following near total thyroidectomy who were referred to our institute for I-131 therapy are retrospectively studied. The patients are divided in two groups. Group 1 revealed complete ablation after one dose of I-131. Group 2 needed more than one dose of I-131 for ablation. 26 patients (28.9%) were Categorized in group 1 and 64 patients (71.1%) in group 2 patients. Comparison between the two groups revealed the highest success rate (Ablation with one dose of I-131) in male patients between 30-50 years of age, with mixed type of differentiated thyroid carcinoma without any evidence of local or distant metastasis.
Eftekhari, M., Hajian, B., Fard-Esfahani, A., & Saghari, M. (2000). Evaluation of response to I-131 ablative therapy in patients with differentiated thyroid carcinoma: A five year retrospective study [Persian]. Iranian Journal of Nuclear Medicine, 8(1), 4-9.
MLA
Mohammad Eftekhari; Behnam Hajian; Armaghan Fard-Esfahani; Mohsen Saghari. "Evaluation of response to I-131 ablative therapy in patients with differentiated thyroid carcinoma: A five year retrospective study [Persian]". Iranian Journal of Nuclear Medicine, 8, 1, 2000, 4-9.
HARVARD
Eftekhari, M., Hajian, B., Fard-Esfahani, A., Saghari, M. (2000). 'Evaluation of response to I-131 ablative therapy in patients with differentiated thyroid carcinoma: A five year retrospective study [Persian]', Iranian Journal of Nuclear Medicine, 8(1), pp. 4-9.
VANCOUVER
Eftekhari, M., Hajian, B., Fard-Esfahani, A., Saghari, M. Evaluation of response to I-131 ablative therapy in patients with differentiated thyroid carcinoma: A five year retrospective study [Persian]. Iranian Journal of Nuclear Medicine, 2000; 8(1): 4-9.
)